Charlotte R. Leung

Charlotte R. Leung

Auto-generated profile, based on publicly available information

Charlotte R. Leung

Tumor Microenvironment and Cancer Immunology Program, National Cancer Institute designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 1

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
NBNumana Bhat
Numana Bhat
RVRichard Virgen-Slane
Richard Virgen-Slane
PRParham Ramezani-Rad
Parham Ramezani-Rad
CLCharlotte R. Leung
Charlotte R. Leung
CCCindi Chen
Cindi Chen
RRRobert C. Rickert
Robert C. Rickert
Regnase-1 is an emerging regulator of immune responses with essential roles in the posttranscriptional control of immune cell activation. Regnase-1 is expressed in B cells; however, its B cell–specific functions remain unknown. Here, we demonstrate that Regnase-1 prevents severe autoimmune pathology and show its essential role in maintaining B cell homeostasis. Using Cre driver mice for ablation of Regnase-1 at various stages of B cell development, we demonstrate that loss of Regnase-1 leads to aberrant B cell activation and differentiation, resulting in systemic autoimmunity and early morbidity. The basis of these findings was informed by gene expression data revealing a regulatory role for Regnase-1 in the suppression of a transcriptional program that promotes B cell activation, survival, and differentiation. Overall, our study shows that Regnase-1 exerts critical control of B cell activation, which is required for prevention of immunopathology.